Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

In a report released yesterday, Mason Carrico from Stephens maintained a Buy rating on Illumina (ILMN – Research Report), with a price target ...

San Diego, CA.-based Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis of genetic variation and function. Using its proprietary technologies ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.

Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN ...

11 analysts have expressed a variety of opinions on Illumina ILMN over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...

SAN DIEGO - Illumina, Inc. (NASDAQ: NASDAQ:ILMN), a $4.37 billion revenue genomics leader with an impressive 68.37% gross margin, today announced a comprehensive suite of new omics technologies ...